Self-Efficacy to Manage Chronic Disease (SEMCD) scale: translation and evaluation of measurement properties for a swedish versionVisa övriga samt affilieringar
2023 (Engelska)Ingår i: Archives of Public Health, ISSN 0778-7367, E-ISSN 2049-3258, Vol. 81, nr 1, artikel-id 2
Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
Background: Reinforcing self-efficacy in patients is important in person-centered care; therefore, reliable and valid measures of a person’s self-efficacy is of clinical relevance. A questionnaire suitable for self-efficacy and patient engagement that is not limited to a particular condition is the Self-efficacy to Manage Chronic Disease (SEMCD). This study aims to evaluate the measurement properties of a Swedish translation of the SEMCD with a Rasch analysis. Methods: The translation and cultural adaptation of the SEMCD was performed according to the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) recommendations. Self-reported data was collected from two cohorts: patients with pituitary tumors (n = 86) and patients on sick leave due to common mental disorders (n = 209). Measurement properties were evaluated with a Rasch analysis in RUMM2030. Results: The original six-item SEMCD did not fit to a unidimensional scale. Two items, item 5 and item 6, deviated both statistically and conceptually and were removed. A four-item solution, the SEMCD-4 with collapsed thresholds for mid-range response options, showed good targeting and unidimensionality, no item misfit, and a reliability of 0.83. Conclusion: In a Swedish context with a mix of patients with pituitary tumors or common mental disorders, SEMCD-4 showed satisfactory measurement properties. Thus, SEMCD-4 could be used to identify patient self-efficacy in long-term illnesses. This knowledge about patient self-efficacy may be of importance to tailor person-centered support based on each patient´s resources, needs and goals. © 2023, The Author(s).
Ort, förlag, år, upplaga, sidor
BioMed Central Ltd , 2023. Vol. 81, nr 1, artikel-id 2
Nyckelord [en]
Rasch analysis, Self-efficacy
Nationell ämneskategori
Medicin och hälsovetenskap
Identifikatorer
URN: urn:nbn:se:ri:diva-62556DOI: 10.1186/s13690-022-01022-xScopus ID: 2-s2.0-85145556840OAI: oai:DiVA.org:ri-62556DiVA, id: diva2:1729766
Anmärkning
Funding details: ALFGBG-719531; Funding details: Västra Götalandsregionen; Funding details: Sahlgrenska Universitetssjukhuset, SU; Funding details: Göteborgs Universitet; Funding details: Forskningsrådet om Hälsa, Arbetsliv och Välfärd, FORTE, 2016–07418, 2017–00557, 2019–01726, ALFGBG-772191, ALFGBG-932659; Funding details: Centrum fÖr Personcentrerad Vård, GPCC; Funding text 1: This research would not have been possible without patient engagement and the extensive data collection within the two different interventional studies. We acknowledge the patients with pituitary tumors that participated in the study and Gudmundur Johannsson and Ann-Charlotte Olofsson from the Department of Endocrinology and Tobias Hallén and Thomas Skoglund from the Department of Neurosurgery at Sahlgrenska University Hospital responsible for the study including patients with pituitary tumors. Furthermore, we gratefully acknowledge the contributions of patients, the participating primary health care centers, managers and health care professionals to the study including patients on sick leave due to CMD.; Funding text 2: Open access funding provided by University of Gothenburg. The PT-study was supported by grants from the Swedish state under agreement between the Swedish government and the county councils, the ALF-agreement (ALFGBG-719531), and The Healthcare Board, Västra Götaland Region in Sweden. The CMD project was supported by the Swedish Research Council for Health, Working Life and Welfare (2016–07418, 2017–00557, and 2019–01726), and was financed by grants from the Swedish state under the agreement between the Swedish government and the country councils, the ALF agreement (ALFGBG-772191 and ALFGBG-932659). This work was also supported by The University of Gothenburg Centre for Person-centred Care (GPCC), Sweden. GPCC is funded by the Swedish Government’s grant for Strategic Research Areas (Care Sciences) and the University of Gothenburg, Sweden.
2023-01-232023-01-232023-05-22Bibliografiskt granskad